These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 28879675

  • 21. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer.
    Jiang X, Du L, Wang L, Li J, Liu Y, Zheng G, Qu A, Zhang X, Pan H, Yang Y, Wang C.
    Int J Cancer; 2015 Feb 15; 136(4):854-62. PubMed ID: 24961907
    [Abstract] [Full Text] [Related]

  • 22. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ, Lin Z, Chen XJ, Song M, Wang YQ, Cai YJ, Yang NB, Zheng MH, Dong JZ, Zhang L, Chen YP.
    Oncotarget; 2015 Sep 22; 6(28):25093-108. PubMed ID: 26231037
    [Abstract] [Full Text] [Related]

  • 23. Prognostic role of microRNA-100 in patients with bladder cancer.
    Cao YH, Zhang HH, Xu HF, Duan YJ, Li Q, Huang B.
    Genet Mol Res; 2015 Dec 07; 14(4):15948-54. PubMed ID: 26662386
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.
    Xie H, Zhu Y, Zhang J, Liu Z, Fu H, Cao Y, Li G, Shen Y, Dai B, Xu J, Ye D.
    BMC Cancer; 2018 May 24; 18(1):590. PubMed ID: 29793447
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
    Inamoto T, Uehara H, Akao Y, Ibuki N, Komura K, Takahara K, Takai T, Uchimoto T, Saito K, Tanda N, Yoshikawa Y, Minami K, Hirano H, Nomi H, Kato R, Hayashi T, Azuma H.
    Dis Markers; 2018 May 24; 2018():5468672. PubMed ID: 30026881
    [Abstract] [Full Text] [Related]

  • 30. MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Meng FM, Meng FM, Song XL.
    Eur Rev Med Pharmacol Sci; 2017 Mar 24; 21(5):973-977. PubMed ID: 28338199
    [Abstract] [Full Text] [Related]

  • 31. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A, Nakagawa T, Kanatani A, Ikeda M, Kawai T, Miyakawa J, Taguchi S, Naito A, Otsuka M, Nakanishi Y, Suzuki M, Koga F, Nagase Y, Kondo Y, Okaneya T, Tanaka Y, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    World J Urol; 2018 Feb 24; 36(2):249-256. PubMed ID: 29185045
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomy.
    Liu W, Qi L, Lv H, Zu X, Chen M, Wang J, Liu L, Zeng F, Li Y.
    BMC Cancer; 2015 Mar 04; 15():92. PubMed ID: 25884322
    [Abstract] [Full Text] [Related]

  • 37. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z, Dai W, Wang X, Chen W, Shen C, Ye G, Li L.
    Tumour Biol; 2016 Jun 04; 37(6):8075-82. PubMed ID: 26715266
    [Abstract] [Full Text] [Related]

  • 38. Serum miR-542-3p as a prognostic biomarker in osteosarcoma.
    Li Q, Song S, Ni G, Li Y, Wang X.
    Cancer Biomark; 2018 Feb 14; 21(3):521-526. PubMed ID: 29103020
    [Abstract] [Full Text] [Related]

  • 39. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
    Liu Y, Cai Q, Bao PP, Su Y, Cai H, Wu J, Ye F, Guo X, Zheng W, Zheng Y, Shu XO.
    Breast Cancer Res Treat; 2015 Jul 14; 152(1):183-191. PubMed ID: 26062749
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.